Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8721773 | Digestive and Liver Disease | 2018 | 27 Pages |
Abstract
In a properly selected group of patients with hepatocellular carcinoma beyond the Milan criteria with clinically relevant portal hypertension, hepatic resection appears to be as safe as TACE and provides a significant survival benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jian Yang, Jia-Yin Yang, Lu-Nan Yan, Tian-Fu Wen, Bo Li, Wen-Tao Wang,